Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR)

  • External authors:
  • J. Galloway
  • A. Ustianowski

Impact

  1. Improving treatment outcomes for patients with rheumatoid arthritis

    Deborah Symmons (Participant), Alan Silman (Participant), Kimme Hyrich (Participant), Mark Lunt (Participant), William Dixon (Participant) & Suzanne Verstappen (Participant)

    Impact: Health impacts, Societal impacts, Economic impacts

Return to publication overview